{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:44:39Z","timestamp":1774993479418,"version":"3.50.1"},"reference-count":24,"publisher":"BMJ","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Ophthalmology"],"published-print":{"date-parts":[[1995,11,1]]},"DOI":"10.1136\/bjo.79.11.996","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:53:19Z","timestamp":1190152399000},"page":"996-1002","source":"Crossref","is-referenced-by-count":43,"title":["Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group."],"prefix":"10.1136","volume":"79","author":[{"given":"M L","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Bron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N A","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A C","family":"Keech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K R","family":"Wallendszus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"MacMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Snibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM198108273050909","article-title":"Lowering plasma cholesterol by raising LDL receptors","volume":"305","author":"Brown, M.S.; Goldstein, J.L.","year":"1981","unstructured":"Brown MS, Goldstein JL. Lowering plasma cholesterol by raising LDL receptors. N Engl J Med 1981; 305: 515-7.","journal-title":"N Engl J Med"},{"issue":"68","key":"ref_2","first-page":"84","article-title":"Cataract formation after Triparanol therapy","volume":"1962","author":"Kirby, T.J.; Achor, R.W.P.; Perry, H.O.; Winkelmann, R.K.","unstructured":"Kirby TJ, Achor RWP, Perry HO, Winkelmann RK. Cataract formation after Triparanol therapy. Arch Ophthalmol 1962; 68: 84-7.","journal-title":"Arch Ophthalmol"},{"key":"ref_3","first-page":"128","article-title":"Triparanol induced cataract in rats","volume":"70","author":"L, Von Sallman; P, Grimes; E, Collins","year":"1963","unstructured":"Von Sallman L, Grimes P, Collins E. Triparanol induced cataract in rats. Arch Ophthalmol 1963; 70: 128-36.","journal-title":"Arch Ophthalmol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000264704","article-title":"Lipids of the Triparanol cataract in the rat","volume":"6","author":"Mizuno, G.; Ellison, E.; Chipault, JR, Harris; J.E.","year":"1974","unstructured":"Mizuno G, Ellison E, Chipault JR, Harris JE. Lipids of the Triparanol cataract in the rat. Ophthalmol Res 1974; 6: 206-15.","journal-title":"Ophthalmol Res"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.CIR.76.3.534","article-title":"New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethyl-glutaryl-coenzyme A reductase","volume":"76","author":"Tobert, J.A.","year":"1987","unstructured":"Tobert JA. New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethyl-glutaryl-coenzyme A reductase. Circulation 1987; 76: 534-8.","journal-title":"Circulation"},{"key":"ref_6","first-page":"28","article-title":"Animal safety and toxicology of simvastatin and related hydroxy-methyl-glutarylcoenzyme A reductase inhibitors","volume":"4","author":"Gerson, R.J.; MacDonald, J.S.; Alberts, A.W.; Kornbrust, B.J.; Majka, V.A.; Stubbs, R.J.","year":"1989","unstructured":"Gerson RJ, MacDonald JS, Alberts AW, Kornbrust BJ, Majka VA, Stubbs RJ, et al. Animal safety and toxicology of simvastatin and related hydroxy-methyl-glutarylcoenzyme A reductase inhibitors. Am Y Med 1989; 87 (4A): 28s-38s.","journal-title":"Am Y Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-4835(90)90012-J","article-title":"On the etiology of subcapsular lenticular opacities produced in dogs receiving HMGCoA reductase inhibitors","volume":"50","author":"true","year":"1990","unstructured":"Gerson RJ, MacDonald JS, Alberts AW, Chen J, Yudkovitz JB, Greenspan MD, et al. On the etiology of subcapsular lenticular opacities produced in dogs receiving HMGCoA reductase inhibitors. Exp Eye Res 1990; 50: 65-78.","journal-title":"Exp Eye Res"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-4835(83)90147-1","article-title":"Source of cholesterol for the ocular lens, studied with U18666A: a cataract producing inhibitor of lipid metabolism","volume":"37","author":"Cenedella, R.J.","year":"1983","unstructured":"Cenedella RJ. Source of cholesterol for the ocular lens, studied with U18666A: a cataract producing inhibitor of lipid metabolism. Exp Eye Res 1983; 37: 33-43.","journal-title":"Exp Eye Res"},{"key":"ref_9","first-page":"643","article-title":"No lens changes caused by simvastatin: results from a prospective drug safety study","volume":"7","year":"1990","unstructured":"Schmidt J, Schmitt C, Hockwin 0. No lens changes caused by simvastatin: results from a prospective drug safety study. Lens Eye Toxic Res 1990; 7: 643-50.","journal-title":"Lens Eye Toxic Res"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1755-3768.1990.tb01689.x","article-title":"Lens changes in matched normals and hyperlipidaemic patients treated with simvastatin for 2 years","volume":"68","author":"Lundh, B.L.; Nilsson, S.E.","year":"1990","unstructured":"Lundh BL, Nilsson SE. Lens changes in matched normals and hyperlipidaemic patients treated with simvastatin for 2 years. Acta Ophthalmol 1990; 68: 658-60.","journal-title":"Acta Ophthalmol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1001\/jama.1986.03380200067023","article-title":"Therapeutic response to lovastatin (mevinolin) in non-familial hypercholesterolemia. A multicenter s, udy","volume":"256","author":"Group, II, The Lovastatin Study","year":"1986","unstructured":"The Lovastatin Study Group II. Therapeutic response to lovastatin (mevinolin) in non-familial hypercholesterolemia. A multicenter s,udy. JAMA 1986; 256: 2829-34.","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/0003-4819-107-5-609","article-title":"Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia","volume":"107","author":"Havel, R.J.; Hunninghake, D.B.; Illingworth, D.R.; Lees, R.S.; Stein, E.A.; Tobert, J.A.","year":"1987","unstructured":"Havel RJ, Hunninghake DB, Illingworth DR, Lees RS, Stein EA, Tobert JA, et al. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. Ann Intern Med 1987; 107: 609-15.","journal-title":"Ann Intern Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0002-9149(91)90182-K","article-title":"Long-term safety and efficacy profile of simvastatin","volume":"68","author":"Boccuzzi, S.J.; Bocanegra, T.S.; Findlay Walker, J.; Shapiro, D.R.; Keegan, M.E.","year":"1991","unstructured":"Boccuzzi SJ, Bocanegra TS, Findlay Walker J, Shapiro DR, Keegan ME. Long-term safety and efficacy profile of simvastatin. Am _J Cardiol 1991; 68: 1127-3 1.","journal-title":"Am _J Cardiol"},{"key":"ref_14","first-page":"443","article-title":"Field test for reliability of new lens opacity rating system utilizing slit-lamp examination","volume":"6","author":"Laties, A.; Keates, E.; Lippa, E.; Shear, C.; Snavely, D.; TupyVisich, M.","year":"1989","unstructured":"Laties A, Keates E, Lippa E, Shear C, Snavely D, TupyVisich M, et al. Field test for reliability of new lens opacity rating system utilizing slit-lamp examination. Lens Eye Toxic Res 1989; 6: 443-64.","journal-title":"Lens Eye Toxic Res"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0002-9149(91)90002-3","article-title":"Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin","volume":"67","author":"Laties, A.M.; Shear, C.L.; Lippa, E.A.; Gould, L.; Taylor, H.R.; Hurley, D.P.","year":"1991","unstructured":"Laties AM, Shear CL, Lippa EA, Gould L, Taylor HR, Hurley DP, et al. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin. AmJ Cardiol 1991; 67: 447-53.","journal-title":"AmJ Cardiol"},{"key":"ref_16","first-page":"255","article-title":"et al for the Oxford Cholesterol Study Group. Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study","volume":"7","author":"Keech, A.; Collins, R.; MacMahon, S.; Armitage, J.; Lawson, A.; Wallendszus, K.","year":"1994","unstructured":"Keech A, Collins R, MacMahon S, Armitage J, Lawson A, Wallendszus K, et al for the Oxford Cholesterol Study Group. Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. Eur Heart J7 1994; 15: 255-69.","journal-title":"Eur Heart"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9394(82)90197-0","article-title":"New visual acuity charts for clinical research","volume":"94","author":"Ferris, F.L.; Kassof, A.; Bresnick, G.H.; Bailey, I.","year":"1982","unstructured":"Ferris FL, Kassof A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94: 91-6.","journal-title":"Am J Ophthalmol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00137534","article-title":"The Oxford clinical cataract classification and grading system","volume":"9","author":"Sparrow, J.M.; Ayliffe, W.; Bron, A.J.; Brown, N.P.; Hill, A.R.","year":"1986","unstructured":"Sparrow JM, Ayliffe W, Bron AJ, Brown NP, Hill AR. The Oxford clinical cataract classification and grading system. Int Ophthalmol 1986; 9: 207-25.","journal-title":"Int Ophthalmol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/eye.1990.89","article-title":"The Oxford modular cataract image analysis system","volume":"4","author":"Sparrow, J.M.; Brown, N.A.P.; Shun-Shin, G.A.; Bron, A.J.","year":"1990","unstructured":"Sparrow JM, Brown NAP, Shun-Shin GA, Bron AJ. The Oxford modular cataract image analysis system. Eye 1990; 4: 638-48.","journal-title":"Eye"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/eye.1991.79","article-title":"Inter and intra observer reproducibility of the new Oxford CCD Scheimpflug camera","volume":"5","author":"Harris, M.L.; Smith, G.T.H.; Brown, N.A.P.","year":"1991","unstructured":"Harris ML, Smith GTH, Brown NAP. Inter and intra observer reproducibility of the new Oxford CCD Scheimpflug camera. Eye 1991; 5: 487-90.","journal-title":"Eye"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/eye.1993.124","article-title":"Analysis of retro-illumination photographs for use in longitudinal studies of cataract","volume":"7","author":"Harris, M.L.; Hanna, K.J.; Shun-Shin, G.A.; Holden, R.; Brown, N.A.P.","year":"1993","unstructured":"Harris ML, Hanna KJ, Shun-Shin GA, Holden R, Brown NAP. Analysis of retro-illumination photographs for use in longitudinal studies of cataract. Eye 1993; 7: 572-7.","journal-title":"Eye"},{"key":"ref_22","article-title":"The lens in diabetes. DPhil Thesis","author":"Sparrow, J.M.","year":"1988","unstructured":"Sparrow JM. The lens in diabetes. DPhil Thesis, Oxford, 1988."},{"key":"ref_23","article-title":"Theoretical Statistics, Chapter 6: Distribution-free and randomisation tests","author":"Cox, D.E.; Hinkley, D.V.","year":"1974","unstructured":"Cox DE, Hinkley DV. Theoretical Statistics, Chapter 6: Distribution-free and randomisation tests. London: Chapman and Hall, 1974."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00130616","article-title":"Interobserver and intraobserver variability of the Oxford Clinical Cataract Classification and Grading System","volume":"11","author":"Sparrow, J.M.; Ayliffe, W.; Bron, A.; Brown, N.A.P.; Hill, A.R.","year":"1988","unstructured":"Sparrow JM, Ayliffe W, Bron A, Brown NAP, Hill AR. Interobserver and intraobserver variability of the Oxford Clinical Cataract Classification and Grading System. Int Ophthalmol 1988; 11: 151-7.","journal-title":"Int Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo.79.11.996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:25:49Z","timestamp":1601115949000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo.79.11.996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11,1]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1995,11,1]]}},"URL":"https:\/\/doi.org\/10.1136\/bjo.79.11.996","relation":{},"ISSN":["0007-1161"],"issn-type":[{"value":"0007-1161","type":"print"}],"subject":[],"published":{"date-parts":[[1995,11,1]]}}}